Insider filing · BBIO
BridgeBio Pharma, Inc.
BBIO · Healthcare · 74 filings in 24 months
ticker →
Viking Global Opportunities Illiquid Investments Sub-Master LP sold $107.0M of BridgeBio Pharma (BBIO)
Executed Jan 31 2025, disclosed Jan 31 2025, the same day.
Value, as filed
$107.0M
3,065,616 sh × $34.90
Executed
Jan 31 2025
the trade date, as filed
Disclosed
Jan 31 2025
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
VL
Viking Global Opportunities Illiquid Investments Sub-Master LP
10% owner
profile →
Viking Global Opportunities Illiquid Investments Sub-Master LP (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $107.0M of BBIO (3,065,616 sh × $34.90, as filed), executed Jan 31 2025.
The name
BBIOHealthcare · BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→